kabutan

M3 falls sharply for third consecutive day to year-to-date low as 8% net profit forecast seen as underwhelming

Thu May 7, 2026 9:29 am JST Catalyst

M3, Inc. <2413> fell sharply for the third consecutive day, hitting a year-to-date low. The company disclosed its earnings forecast for the fiscal year ending March 2027 after the close of trading on the 1st, along with its consolidated financial results for the fiscal year ended March 2026. For the current fiscal year, M3 Inc projects sales of 400 billion yen, up 13.8% year-on-year, and net profit of 53 billion yen, up 7.9%. While the company also announced a share buyback program with an upper limit of 20 million shares (3.00% of issued shares excluding treasury stock) and 20 billion yen, the profit forecast level was perceived as underwhelming, prompting selling pressure.

The share repurchase period runs from May 2 to April 30 of next year. For the current fiscal year, the company expects continued growth in medical field DX-related areas. In the career solutions segment, the business for physicians and pharmacists is expected to remain solid. For the fiscal year ended March 2026, sales increased 23.3% year-on-year to 351.363 billion yen, and net profit rose 21.3% to 49.1 billion yen.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles